Use of antisense oligonucleotides to target Notch3 in skeletal cells. Canalis E, Carrer M, Eller T, Schilling L, et al. PLoS One 2022;17:e0268225.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Canalis E, Carrer M, Eller T, Schilling L, et al. Use of antisense oligonucleotides to target Notch3 in skeletal cells. PLoS One 2022;17:e0268225.
PMID: 35536858